BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25943777)

  • 1. Granulosa Cell-Specific Brca1 Loss Alone or Combined with Trp53 Haploinsufficiency and Transgenic FSH Expression Fails to Induce Ovarian Tumors.
    Upton DH; Fuller ES; Colvin EK; Walters KA; Jimenez M; Desai R; Handelsman DJ; Howell VM; Allan CM
    Horm Cancer; 2015 Aug; 6(4):142-52. PubMed ID: 25943777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global or Granulosa Cell-Specific Pten Mutations in Combination with Elevated FSH Levels Fail to Cause Ovarian Tumours in Mice.
    Upton DH; Walters KA; Allavena RE; Jimenez M; Desai R; Handelsman DJ; Allan CM
    Horm Cancer; 2016 Dec; 7(5-6):316-326. PubMed ID: 27506975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian tumorigenesis in mice transgenic for murine inhibin alpha subunit promoter-driven Simian Virus 40 T-antigen: ontogeny, functional characteristics, and endocrine effects.
    Rahman NA; Huhtaniemi IT
    Biol Reprod; 2001 Apr; 64(4):1122-30. PubMed ID: 11259258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis.
    Kumar TR; Palapattu G; Wang P; Woodruff TK; Boime I; Byrne MC; Matzuk MM
    Mol Endocrinol; 1999 Jun; 13(6):851-65. PubMed ID: 10379885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follicle-stimulating hormone regulation of estradiol production: possible involvement of WNT2 and β-catenin in bovine granulosa cells.
    Castañon BI; Stapp AD; Gifford CA; Spicer LJ; Hallford DM; Hernandez Gifford JA
    J Anim Sci; 2012 Nov; 90(11):3789-97. PubMed ID: 22696613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in Brca1 expression in mouse ovarian granulosa cells have short-term and long-term consequences on estrogen-responsive organs.
    Yen HY; Gabet Y; Liu Y; Martin A; Wu NL; Pike MC; Frenkel B; Maxson R; Dubeau L
    Lab Invest; 2012 Jun; 92(6):802-11. PubMed ID: 22488153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of ovarian leiomyosarcomas in mice by conditional inactivation of Brca1 and p53.
    Quinn BA; Brake T; Hua X; Baxter-Jones K; Litwin S; Ellenson LH; Connolly DC
    PLoS One; 2009 Dec; 4(12):e8404. PubMed ID: 20046879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-nonautonomous induction of ovarian and uterine serous cystadenomas in mice lacking a functional Brca1 in ovarian granulosa cells.
    Chodankar R; Kwang S; Sangiorgi F; Hong H; Yen HY; Deng C; Pike MC; Shuler CF; Maxson R; Dubeau L
    Curr Biol; 2005 Mar; 15(6):561-5. PubMed ID: 15797026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems.
    Wang J; Lin L; Parkash V; Schwartz PE; Lauchlan SC; Zheng W
    Int J Cancer; 2003 Jan; 103(3):328-34. PubMed ID: 12471615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mouse model for the molecular characterization of brca1-associated ovarian carcinoma.
    Xing D; Orsulic S
    Cancer Res; 2006 Sep; 66(18):8949-53. PubMed ID: 16982732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional inactivation of Brca1, p53 and Rb in mouse ovaries results in the development of leiomyosarcomas.
    Clark-Knowles KV; Senterman MK; Collins O; Vanderhyden BC
    PLoS One; 2009 Dec; 4(12):e8534. PubMed ID: 20046869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FSH inhibits AMH to support ovarian estradiol synthesis in infantile mice.
    Devillers MM; Petit F; Cluzet V; François CM; Giton F; Garrel G; Cohen-Tannoudji J; Guigon CJ
    J Endocrinol; 2019 Feb; 240(2):215-228. PubMed ID: 30403655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of cytokinesis failure in ovarian cystadenomas with defective BRCA1 and P53 pathways.
    Austria T; Marion C; Yu V; Widschwendter M; Hinton DR; Dubeau L
    Int J Cancer; 2018 Dec; 143(11):2932-2942. PubMed ID: 29978915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulosa cell and oocyte mitochondrial abnormalities in a mouse model of fragile X primary ovarian insufficiency.
    Conca Dioguardi C; Uslu B; Haynes M; Kurus M; Gul M; Miao DQ; De Santis L; Ferrari M; Bellone S; Santin A; Giulivi C; Hoffman G; Usdin K; Johnson J
    Mol Hum Reprod; 2016 Jun; 22(6):384-96. PubMed ID: 26965313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the transcription factor E2F1 mRNA in ovarian granulosa cells of cattle.
    Morrell BC; Perego MC; Maylem ERS; Zhang L; Schütz LF; Spicer LJ
    J Anim Sci; 2020 Jan; 98(1):. PubMed ID: 31832639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the mouse estrus cycle in response to BRCA1 inactivation suggest a potential link between risk factors for familial and sporadic ovarian cancer.
    Hong H; Yen HY; Brockmeyer A; Liu Y; Chodankar R; Pike MC; Stanczyk FZ; Maxson R; Dubeau L
    Cancer Res; 2010 Jan; 70(1):221-8. PubMed ID: 20028858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between the antral follicle count, steroidogenesis, and secretion of follicle-stimulating hormone and anti-Müllerian hormone during follicular growth in cattle.
    Sakaguchi K; Yanagawa Y; Yoshioka K; Suda T; Katagiri S; Nagano M
    Reprod Biol Endocrinol; 2019 Nov; 17(1):88. PubMed ID: 31690325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatiotemporal expression of epidermal growth factor receptor messenger RNA and protein in the hamster ovary: follicle stage-specific differential modulation by follicle-stimulating hormone, luteinizing hormone, estradiol, and progesterone.
    Garnett K; Wang J; Roy SK
    Biol Reprod; 2002 Nov; 67(5):1593-604. PubMed ID: 12390893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary and ovarian expression of the endogenous follicle-stimulating hormone (FSH) subunit genes and an FSH beta-subunit promoter-driven herpes simplex virus thymidine kinase gene in transgenic mice; specific partial ablation of FSH-producing cells by antiherpes treatment.
    Markkula M; Kananen K; Klemi P; Huhtaniemi I
    J Endocrinol; 1996 Aug; 150(2):265-73. PubMed ID: 8869593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global deletion of Trp53 reverts ovarian tumor phenotype of the germ cell-deficient white spotting variant (Wv) mice.
    Cai KQ; Wang Y; Smith ER; Smedberg JL; Yang DH; Yang WL; Xu XX
    Neoplasia; 2015 Jan; 17(1):89-100. PubMed ID: 25622902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.